89bio Announces Pricing Of Previously Announced Upsized Underwritten Public Offering Of 15,135,135 Shares At $9.25 Per Share
Portfolio Pulse from Benzinga Newsdesk
89bio, Inc. has announced the pricing of its upsized underwritten public offering of 15,135,135 shares at a price of $9.25 per share. This follows a previous announcement about the public offering.

December 07, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
89bio, Inc. has priced its upsized public offering at $9.25 per share, which may influence the stock's short term performance depending on investor reception.
The pricing of a public offering can have a direct impact on the stock price of a company. In the short term, the market's reaction to 89bio's offering price will depend on whether investors view the price as attractive and whether the offering is seen as dilutive to current shareholders. Given that the offering was upsized, it suggests a positive reception or a need for more capital, which could be interpreted in various ways by the market.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100